跳至主要内容
临床试验/TCTR20181001002
TCTR20181001002招募中2 期

EUS-guided choledocho-duodenostomy versus ERCP with covered metallic stents in patients with unresectable malignant distal common bile duct strictures: a multi-center randomized controlled trial

Chinese University of Hong Kong0 个研究点目标入组 10 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Consecutive patients aged ≥ 18 years old admitted for obstructive jaundice due to unresectable distal CBD malignancy
  • 2. Eligible for endoscopic intervention
  • 3. Written informed consent

排除标准

  • 1. Multiple hepatic metastases involving >30% of the liver parenchyma
  • 2. Presence of main portal vein thrombosis
  • 3. Locally advanced malignancy scheduled for neoadjuvant chemotherapy or radiotherapy
  • 4. Extensive tumor involvement of the 1st part of duodenum resulting in tissue thickness between the bile duct and duodenum of ≥ 8mm
  • 5. Prior SEMS placement
  • 6. Intraductal papillary
  • mucinous carcinomas
  • 7. Prior Billroth II or roux-en Y reconstruction
  • 8. Bleeding disorder or use of anticoagulation
  • 9. Child’s B/C cirrhosis
  • 10. Pregnancy
  • 11. Performance status ECOG ≥3 (
  • 12. Presence of other malignancy
  • 13. Life expectancy < 3months

研究者

相似试验